Director/PDMR Shareholding
18 May 2021 15:30 BST Transaction by Person Discharging Managerial Responsibilities AstraZeneca PLC (the Company) announced that on 14 May 2021, Pascal Soriot, Chief Executive Officer, was granted an award of the Company's ordinary shares of $0.25 each (Ordinary Shares) under the terms of the AstraZeneca Performance Share Plan (AZPSP), as detailed in the table below. This award forms part of the AZPSP award granted to Mr Soriot on 5 March 2021. As described in AstraZeneca's 2020 Directors' Remuneration Report, it has been made in accordance with the Directors' Remuneration Policy